How many national patents have JinNaLing refined tablets obtained?

Four projects. According to the inquiry of official website of Beijing Cantiny Pharmaceutical Co., Ltd., Jinnaling refined tablets were developed by Beijing Cantiny Pharmaceutical Co., Ltd., and its raw materials were certified by Hubei Science and Technology Department for many scientific and technological achievements, and four national invention patents were applied for and obtained. It is a product that can prevent cardiovascular diseases, and its main component is sturgeon protein peptide, which has a good effect on cleaning up toxins in blood and accelerating metabolism.